Levels of mRNA for dopaminergic receptor D5 in circulating lymphocytes may be associated with subsequent response to interferon-β in patients with multiple sclerosis
Authors:
- 1 December 2014
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 277 (1-2) , 193-196
Abstract
No abstract availableKeywords
Funding Information
- University of Insubria (FAR 2002)
- Italian Foundation for Multiple Sclerosis (#2003/R/67)
This publication has 24 references indexed in Scilit:
- Multiple SclerosisAnnals of Internal Medicine, 2014
- Adrenergic and Dopaminergic Modulation of Immunity in Multiple Sclerosis: Teaching Old Drugs New Tricks?Journal of Neuroimmune Pharmacology, 2012
- The Physiology, Signaling, and Pharmacology of Dopamine ReceptorsPharmacological Reviews, 2011
- Immunopathogenesis and immunotherapy of multiple sclerosisNature Clinical Practice Neurology, 2006
- Multiple Sclerosis — The Plaque and Its PathogenesisNew England Journal of Medicine, 2006
- Dopamine Fails to Regulate Activation of Peripheral Blood Lymphocytes from Multiple Sclerosis Patients: Effects of IFN-βJournal of Interferon & Cytokine Research, 2005
- Interferon-γ and interferon-β affect endogenous catecholamines in human peripheral blood mononuclear cells: Implications for multiple sclerosisJournal of Neuroimmunology, 2005
- Post-receptorial mechanisms underlie functional disregulation of β2-adrenergic receptors in lymphocytes from Multiple Sclerosis patientsJournal of Neuroimmunology, 2004
- Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosisJournal of Neuroimmunology, 2002
- Interferon beta in multiple sclerosisNeurology, 1993